The Cortical Electrode Market is becoming an important component of the broader neurotechnology landscape, with applications spanning neuroprosthetics, brain mapping, seizure monitoring, and neuroscience research. The market reached approximately USD 2.3 billion in 2025 and is projected to expand to USD 4.5 billion by 2035 at a CAGR of 7.1%.

One of the strongest opportunities lies in neuroprosthetics, where cortical electrodes can help capture neural signals for advanced brain-machine interfaces. Brain mapping is another significant application, supporting efforts to better understand cortical functions and improve the precision of neurological procedures. Seizure monitoring remains important as healthcare systems seek improved technologies for evaluating epilepsy and related conditions.

Product innovation is moving toward electrodes that offer improved flexibility, signal quality, and integration. Intracortical electrodes provide direct access to neural signals, while flexible electrodes are being developed to conform more closely to biological surfaces. Wireless and implantable approaches are also attracting attention as manufacturers seek to expand the capabilities of neural interfaces.

Regional development will remain an important factor. North America benefits from strong healthcare infrastructure and research investment, while Europe continues to expand its clinical and research applications. Asia Pacific is expected to show particularly strong growth as patient populations increase, healthcare technology improves, and demand for neuromonitoring and therapeutic interventions rises.

The market's longer-term direction will depend on continued research into biocompatible materials, miniaturized devices, AI-supported analysis, and personalized neural interfaces. Increasing collaboration between technology companies, medical-device developers, and academic institutions can further accelerate innovation and broaden the practical applications of cortical electrode systems.